中国癌症防治杂志2025，Vol.17Issue(3)：264-272,9.DOI:10.3969/j.issn.1674-5671.2025.03.02
肝胆胰腺肿瘤研究热点与前沿动态:基于ASCO-GI 2025年会
ASCO-GI 2025:Research priorities and emerging frontiers in hepatobiliary and pancreatic cancers
摘要
Abstract
The 2025 American Society of Clinical Oncology-Gastrointestinal Cancers Symposium(ASCO-GI),convened in San Francisco,USA,from January 23 to 25,2025,focused on pivotal topics within the fields of liver cancer,biliary tract cancer,and pancreatic cancer.Key areas of discussion included immunotherapy,targeted therapy,the integration of locoregional and systemic therapy,and precision medicine,all underscoring numerous research findings of significant clinical relevance.These studies provide new evidence-based insights for the diagnosis and treatment of hepatobiliary and pancreatic tumors,offering valuable references for addressing unresolved clinical challenges and optimizing therapeutic strategies.This article systematically reviews the cutting-edge advancements in hepatobiliary and pancreatic tumors reported in ASCO-GI 2025,conducts an in-depth analysis of their clinical application value,and explores future research directions.关键词
肝肿瘤/胆道肿瘤/胰腺肿瘤/2025年美国临床肿瘤学会胃肠道肿瘤研讨会/免疫治疗/靶向治疗/精准治疗Key words
Liver cancer/Bilianry tract cancer/Pancreatic cancer/The 2025 American Society of Clinical Oncology-Gastrointestinal Cancers Symposium/Immunotherapy/Targeted therapy/Precision treatment分类
医药卫生引用本文复制引用
邱国高,GUIDANCE研究协作组,王进明,陈树昌,刘绍平,苏泽,董小锋,黎乐群,钟鉴宏,马良..肝胆胰腺肿瘤研究热点与前沿动态:基于ASCO-GI 2025年会[J].中国癌症防治杂志,2025,17(3):264-272,9.基金项目
广西重点研发项目(桂科AB25069099 （）
桂科AB24010082) （）
国家自然科学基金项目(82260569) （82260569）
广西中医药适宜技术开发与推广项目(GZSY23-66) （GZSY23-66）
